JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B4809 K-115

Summary: Selective Rho kinase inhibitor

insoluble in EtOH; ≥123.2 mg/mL
B4934 ML 349

Summary: lysophospholipase 2 (LYPLA2) inhibitor

Soluble in DMSO
B4953 Methylprednisolone Sodium Succinate

Target: Glucocorticoid Receptors

Summary: glucocorticoid

≥49.7 mg/mL
B5940 TP-0903

Target: AXL

Summary: AXL receptor tyrosine kinase inhibitor, anti-cancer agent

≥25.8 mg/mL
B6031 GMX1778 (CHS828)

Summary: NAMPT inhibitor

insoluble in H2O; insoluble in EtOH; ≥18.3 mg/mL
L1021 DiscoveryProbe™ FDA-approved Drug Library
70 Citation

Summary: 2320 approved drugs and API from pharmacopoeia
B6075 Monastrol

Summary: Eg5 inhibitor
L1033 DiscoveryProbe™ DNA Damage/DNA Repair Library

Summary: A unique collection of 481 DNA Damage/DNA repair-related compounds for DNA damage/DNA repair research.
L1035 DiscoveryProbe™ Protease Inhibitor Library
1 Citation

Summary: A unique collection of 825 protease inhibitors for high throughput screening (HTS) and high content screening (HCS).
B6096 SIS3

Summary: Smad3 inhibitor

≥49 mg/mL